2021 CSCO highlights you missed are all here~

The "24th National Conference on Clinical Oncology and 2021 CSCO Annual Conference" jointly sponsored by the Chinese Society of Clinical Oncology (CSCO) and Beijing Xisk Clinical Oncology Research Foundation will be held on September 25-29, 2021 The day was held in a combination of online and offline
.

The theme of this conference is "Focus on Innovative Research, Leading the Future of Originality"
.

During the conference, [Yimaitong] selected cutting-edge developments and invited experts to interview and reported.
This article summarizes the previous reports to help readers get all the highlights of the conference
.

All you missed are here~~~ Click on the following title to view the original Expert Interview 1.
2021 CSCO Expert Interview｜Professor Ma Jun: Hematological tumors are progressing rapidly, and there is a long way to go for standardized diagnosis and treatment 2.
2021 CSCO Expert Interview｜Professor Zhu Jun: lonca shows initial efficacy, and the prospects for the use of new R/R DLBCL drugs are worth looking forward to 3.
2021 CSCO expert interview | Professor Zhang Yizhu: new progress in the treatment of lymphoma in children and adolescents 4.
2021 CSCO expert interview | Professor Cai Qingqing talks about diffuse large B cells Lymphoma treatment progress 5.
2021 CSCO expert interview | Professor Deng Qi talks about the treatment progress of extramedullary multiple myeloma 6.
2021 CSCO innovation prospects | Professor Zhang Wei analyzes the "breaking" road of otuzumab in the treatment of indolent lymphoma 7 .
2021 CSCOProfessor Qiu Lugui and Professor Fu Weijun work together to interpret the wonderful performance of selinexor in the treatment of multiple myeloma.
Conference Express 1.
2021 CSCO | Professor Chen Wenming: Progress in the treatment of relapsed and refractory multiple myeloma 2.
2021 CSCO | Professor Xu Wei: Research Progress in Chronic Lymphocytic Leukemia 3.
2021 CSCO | Professor Bai Ou: DLBCL Prognosis Exploration and Treatment Optimization 4.
2021 CSCO | Professor Song Yuqin: The establishment of a lymphoma specialist is imperative 5.
2021 CSCO | Professor Li Xiaoqiu: Taking pathology as the cornerstone to promote the development of lymphoma specialist construction projects 6.
2021 CSCO | Professor Zhou Guoren: The harm and full management of tumor-related anemia 7.
2021 CSCO | Professor Li Zhiming: Progress in the treatment of Hodgkin’s lymphoma 8.
2021 CSCO | Professor Gong Tiejun: Progress in the treatment of acute lymphoblastic leukemia 9.
2021 CSCO | Professor Liang Aibin: Full management of CAR-T treatment 10.
2021 CSCO | Professor Cao Junning: Progress in the treatment of Hodgkin’s lymphoma 11.
2021 CSCO | Professor Li Yexiong talks about the important role of radiotherapy in the treatment of indolent lymphoma.
12.
The CSCO annual meeting will be held in 2021.
Roche’s latest blood product R&D pipeline is "exposed", creating a new pattern for lymphoma treatment.
13.
2021 CSCO | WuXi Juno Satellite Symposium: Based on China, forging ahead, Benoda ® helps patients with long-term survival benefit.
"Read the original text" and we will make progress together